更正：伐杜司他在健康志愿者和慢性肾病患者中的药代动力学、药效学和安全性。

IF 5.5 2区医学 Q1 PHARMACOLOGY & PHARMACY

Clinical Pharmacology & Therapeutics Pub Date : 2024-11-08 DOI:10.1002/cpt.3483

{"title":"更正：伐杜司他在健康志愿者和慢性肾病患者中的药代动力学、药效学和安全性。","authors":"","doi":"10.1002/cpt.3483","DOIUrl":null,"url":null,"abstract":"Navarro-Gonzales, P., Ganz, T., Pergola, P.E., Zuk, A. & Dykstra, K. Pharmacokinetics, pharmacodynamics, and safety of vadadustat in healthy volunteers and patients with chronic kidney disease. Clin. Pharmacol. Ther. 116:1052–1061 (2024). https://doi.org/10.1002/cpt.3342The authors would like to add the following to the Acknowledgments section:“We thank Robert R. Shalwitz, M.D., Isaiah R. Shalwitz, M.S., and Akshay Buch, Ph.D., for their early work on the inception of these studies.”The authors apologize for this omission.","PeriodicalId":153,"journal":{"name":"Clinical Pharmacology & Therapeutics","volume":"117 1","pages":""},"PeriodicalIF":5.5000,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cpt.3483","citationCount":"0","resultStr":"{\"title\":\"Correction to: Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Healthy Volunteers and Patients with Chronic Kidney Disease\",\"authors\":\"\",\"doi\":\"10.1002/cpt.3483\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Navarro-Gonzales, P., Ganz, T., Pergola, P.E., Zuk, A. & Dykstra, K. Pharmacokinetics, pharmacodynamics, and safety of vadadustat in healthy volunteers and patients with chronic kidney disease. Clin. Pharmacol. Ther. 116:1052–1061 (2024). https://doi.org/10.1002/cpt.3342The authors would like to add the following to the Acknowledgments section:“We thank Robert R. Shalwitz, M.D., Isaiah R. Shalwitz, M.S., and Akshay Buch, Ph.D., for their early work on the inception of these studies.”The authors apologize for this omission.\",\"PeriodicalId\":153,\"journal\":{\"name\":\"Clinical Pharmacology & Therapeutics\",\"volume\":\"117 1\",\"pages\":\"\"},\"PeriodicalIF\":5.5000,\"publicationDate\":\"2024-11-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cpt.3483\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Pharmacology & Therapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.3483\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Pharmacology & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.3483","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}

引用次数: 0

摘要

纳瓦罗-冈萨雷斯，P.，甘兹，T.，佩戈拉，p.e.，祖克，A. &；vadadustat在健康志愿者和慢性肾脏疾病患者中的药代动力学、药效学和安全性。中国。杂志。[j] . 116:1052-1061（2024）。https://doi.org/10.1002/cpt.3342The作者希望在致谢部分添加以下内容：“我们感谢Robert R. Shalwitz, m.d., Isaiah R. Shalwitz, m.s.和Akshay Buch， Ph.D.在这些研究开始的早期工作。”作者对这一遗漏表示歉意。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Correction to: Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Healthy Volunteers and Patients with Chronic Kidney Disease

查看原文本刊更多论文

Correction to: Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Healthy Volunteers and Patients with Chronic Kidney Disease

Navarro-Gonzales, P., Ganz, T., Pergola, P.E., Zuk, A. & Dykstra, K. Pharmacokinetics, pharmacodynamics, and safety of vadadustat in healthy volunteers and patients with chronic kidney disease. Clin. Pharmacol. Ther. 116:1052–1061 (2024). https://doi.org/10.1002/cpt.3342

The authors would like to add the following to the Acknowledgments section:

“We thank Robert R. Shalwitz, M.D., Isaiah R. Shalwitz, M.S., and Akshay Buch, Ph.D., for their early work on the inception of these studies.”

The authors apologize for this omission.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinical Pharmacology & Therapeutics 医学-药学

CiteScore

12.70

自引率

7.50%

发文量

290

审稿时长

2 months

期刊介绍： Clinical Pharmacology & Therapeutics (CPT) is the authoritative cross-disciplinary journal in experimental and clinical medicine devoted to publishing advances in the nature, action, efficacy, and evaluation of therapeutics. CPT welcomes original Articles in the emerging areas of translational, predictive and personalized medicine; new therapeutic modalities including gene and cell therapies; pharmacogenomics, proteomics and metabolomics; bioinformation and applied systems biology complementing areas of pharmacokinetics and pharmacodynamics, human investigation and clinical trials, pharmacovigilence, pharmacoepidemiology, pharmacometrics, and population pharmacology.